LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) Operating income 2016–2025
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) annual operating income history from SEC filings — each fiscal year as reported.
-$5.1MFY2025 · since FY2016: -$2.1M → -$5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.1M | -43.0% |
| FY2024 | -$3.6M | +29.8% |
| FY2023 | -$5.1M | +19.3% |
| FY2022 | -$6.3M | +6.1% |
| FY2021 | -$6.7M | -105.7% |
| FY2020 | -$3.3M | -31.2% |
| FY2019 | -$2.5M | -16.5% |
| FY2018 | -$2.1M | -18.1% |
| FY2017 | -$1.8M | +15.2% |
| FY2016 | -$2.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice